Literature DB >> 25644274

Visualization of local abnormal ventricular activities in scar-related ventricular tachycardia. A novel strategy.

Harilaos Bogossian1, Gerrit Frommeyer, Bernd Lemke, Markus Zarse.   

Abstract

BACKGROUND: A 73-year old man was admitted for ventricular tachycardia (VT) ablation due to symptomatic sustained VT-initiated VVI-ICD therapies.
RESULTS: Based on voltage mapping, the initial ablation did not result in the endpoint noninducibility of VT. Using a new visualization technique, we mapped the discriminated local abnormal ventricular activations (LAVAs) within the scar which could then be ablated  successfully.
CONCLUSIONS: This new visualization method may be helpful especially in patients with ischemic cardiomyopathy, extensive scars, and frequent LAVAs to identify further areas suited for ablation.

Entities:  

Mesh:

Year:  2015        PMID: 25644274     DOI: 10.1007/s00399-015-0347-9

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  3 in total

1.  Substrate mapping vs. tachycardia mapping using CARTO in patients with coronary artery disease and ventricular tachycardia: impact on outcome of catheter ablation.

Authors:  Marius Volkmer; Feifan Ouyang; Florian Deger; Sabine Ernst; Masahiko Goya; Dietmar Bänsch; Katharina Berodt; Karl-Heinz Kuck; Matthias Antz
Journal:  Europace       Date:  2006-11       Impact factor: 5.214

2.  Changes in the propagation pattern within the conduction channel during sinus rhythm and ventricular tachycardia demonstrated by non-contact mapping: role of late potential activity.

Authors:  Pasquale Vergara; Nicola Trevisi; Annarita Bisceglie; Paolo Della Bella
Journal:  Europace       Date:  2012-08       Impact factor: 5.214

3.  Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia.

Authors:  Pierre Jaïs; Philippe Maury; Paul Khairy; Frédéric Sacher; Isabelle Nault; Yuki Komatsu; Mélèze Hocini; Andrei Forclaz; Amir S Jadidi; Rukshen Weerasooryia; Ashok Shah; Nicolas Derval; Hubert Cochet; Sebastien Knecht; Shinsuke Miyazaki; Nick Linton; Lena Rivard; Matthew Wright; Stephen B Wilton; Daniel Scherr; Patrizio Pascale; Laurent Roten; Michala Pederson; Pierre Bordachar; François Laurent; Steven J Kim; Philippe Ritter; Jacques Clementy; Michel Haïssaguerre
Journal:  Circulation       Date:  2012-04-04       Impact factor: 29.690

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.